Absence of modulatory effects of 6Hz cerebellar transcranial alternating current stimulation on fear learning in men

Front Hum Neurosci. 2024 Jan 9:17:1328283. doi: 10.3389/fnhum.2023.1328283. eCollection 2023.

Abstract

Fear is a vital defense mechanism to potential threats, which is influenced by the cerebellum. While the cerebellum's role in acquiring fear responses is well understood, limited knowledge exists about its involvement in fear extinction. In this study, we investigated the effects of cerebellar theta band transcranial alternating current stimulation (ctACS) administered during fear extinction training, based on previous evidence from animal studies suggesting a role of cerebellar theta oscillations in associative memory formation. To this end, thirty-seven healthy right-handed male participants were recruited for a two-day differential fear renewal paradigm. On day 1, they underwent acquisition training in context A followed by extinction training in context B. On day 2, recall was tested in contexts A and B. One group of participants received ctACS in the theta band (6 Hz) during extinction training. The other group received sham ctACS. Although both groups demonstrated the ability to recall previously learned fear and distinguish between low and high threat stimuli, no significant differences were observed between the ctACS and sham groups, indicating that ctACS at this theta frequency range did not impact extinction and recall of previously acquired fear in this study. Nevertheless, using ctACS could still be useful in future research, including brain imaging studies, to better understand how the cerebellum is involved in fear and extinction processes.

Keywords: associative learning; aversive conditioning; fear conditioning; non-invasive brain stimulation; pavlovian conditioning; transcranial alternating current stimulation.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of the article. This work was supported by a grant from the German Research Foundation (DFG; project number 316803389−SFB 1280) to DT (subproject A05), CM (subproject A09), MN (subproject A06) and GB (treasure chest grant of the SFB 1280). At the time of this study AT held a position funded in part by the German Research Foundation (DFG) and in part by the University Medicine Essen Clinician Scientist Academy (UMEA; grant number FU356/12-2).